» Authors » Valerie Hopkins

Valerie Hopkins

Explore the profile of Valerie Hopkins including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 194
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mosavie M, Rynne J, Fish M, Smith P, Jennings A, Singh S, et al.
Vaccines (Basel) . 2024 Sep; 12(9). PMID: 39340069
Molecular changes in lymphocytes following SARS-CoV-2 vaccination are incompletely understood. We hypothesized that studying the molecular (transcriptomic, epigenetic, and T cell receptor (TCR) repertoire) changes in CD4 T cells following...
2.
Richards J, Summers D, Sidders A, Allen E, Ayaz Hossain M, Paul S, et al.
Health Technol Assess . 2024 May; 28(24):1-54. PMID: 38768043
Background: Arteriovenous fistulas are considered the best option for haemodialysis provision, but as many as 30% fail to mature or suffer early failure. Objective: To assess the feasibility of performing...
3.
Richards J, Summers D, Sidders A, Allen E, Thomas H, Ayaz Hossain M, et al.
Kidney Int Rep . 2024 May; 9(4):1005-1019. PMID: 38765580
Introduction: We assess if ultrasound surveillance of newly-created arteriovenous fistulas (AVFs) can predict nonmaturation sufficiently reliably to justify randomized controlled trial (RCT) evaluation of ultrasound-directed salvage intervention. Methods: Consenting adults...
4.
Moore C, DAmore A, Fustolo-Gunnink S, Hudson C, Newton A, Santamaria B, et al.
Arch Dis Child Fetal Neonatal Ed . 2023 Feb; 108(5):452-457. PMID: 36810309
Objective: Assess mortality and neurodevelopmental outcomes at 2 years of corrected age in children who participated in the PlaNeT-2/MATISSE (Platelets for Neonatal Transfusion - 2/Management of Thrombocytopenia in Special Subgroup)...
5.
Harvala H, Nguyen D, Simmonds P, Lamikanra A, Tsang H, Otter A, et al.
Transfusion . 2022 May; 62(7):1347-1354. PMID: 35588314
Background: The therapeutic benefit of convalescent plasma (CP) therapy to treat COVID-19 may derive from neutralizing antibodies (nAbs) to SARS-CoV-2. To investigate the effects of antigenic variation on neutralization potency...
6.
7.
Stanworth S, Killick S, McQuilten Z, Karakantza M, Weinkove R, Smethurst H, et al.
Br J Haematol . 2020 Jan; 189(2):279-290. PMID: 31960409
Optimal red cell transfusion support in myelodysplastic syndromes (MDS) has not been tested and established. The aim of this study was to demonstrate feasibility of recruitment and follow-up in an...
8.
Richards J, Hossain M, Summers D, Slater M, Bartlett M, Kosmoliaptsis V, et al.
BMJ Open . 2019 Jul; 9(7):e031210. PMID: 31340975
Introduction: Arteriovenous fistulas (AVFs) are considered the best and safest modality for providing haemodialysis in patients with end-stage renal disease. Only 20% of UK centres achieve the recommended 80% target...
9.
Curley A, Stanworth S, Willoughby K, Fustolo-Gunnink S, Venkatesh V, Hudson C, et al.
N Engl J Med . 2018 Nov; 380(3):242-251. PMID: 30387697
Background: Platelet transfusions are commonly used to prevent bleeding in preterm infants with thrombocytopenia. Data are lacking to provide guidance regarding thresholds for prophylactic platelet transfusions in preterm neonates with...
10.
Curry N, Foley C, Wong H, Mora A, Curnow E, Zarankaite A, et al.
Crit Care . 2018 Jun; 22(1):164. PMID: 29914530
Background: There is increasing interest in the timely administration of concentrated sources of fibrinogen to patients with major traumatic bleeding. Following evaluation of early cryoprecipitate in the CRYOSTAT 1 trial,...